New animal drugs in genetically engineered animals (21 CFR 528.1070-528.2010).
Country
Type of law
Regulation
Date of original text
Date of latest amendment
Abstract
Part 528 of Title 21 of the Federal Code of Regulations prescribes the technical and procedural issues regarding the application/use of new animal drugs in genetically engineered animals.
This Regulation provides terms and rules regarding the following substances: Bc6 recombinant deoxyribonucleic acid construct; 528.1092 opAFP–GHc2 recombinant deoxyribonucleic acid construct; 528.2010 Human lysosomal acid lipase recombinant deoxyribonucleic acid construct
This Regulation provides terms and rules regarding the following substances: Bc6 recombinant deoxyribonucleic acid construct; 528.1092 opAFP–GHc2 recombinant deoxyribonucleic acid construct; 528.2010 Human lysosomal acid lipase recombinant deoxyribonucleic acid construct
Attached files
Web site
Notes
Official reprint dated 1 April 2016.
Repealed
No
Serial Imprint
Code of Federal Regulations - Title 21 - Food and Drugs.
Source language
English
Legislation Amendment
No